Facts about asthma:
26 million people in the US currently suffer from asthma
10.7 million of patients with asthma have reported having at least one asthma attack in the past year
Asthma costs $56 billion every year in medicine, hospitalizations, missed school days, and missed work days
There are 15.3 million hospital visits for asthma annually
Asthma is responsible for 1.8 million emergency room visits every year
Asthma is the leading cause of student absences at a rate of 10.5 million days a year
Benefits of preventative care:
Reduced cost associated with treatment
Increased productivity at work and school
Improved patient satisfaction and quality of life
Asthma is considered the most common chronic illness among both children and adults. The U.S. Department of Health and Human Services declared asthma an epidemic 15 years ago and has been working tirelessly to reduce asthma rates and costs. However, rates of asthma have only increased and healthcare costs have skyrocketed. The failure to reduce asthma rates can be attributed to its difficulty to manage and the lack of inexpensive and reliable methods to manage asthma. Mismanagement has resulted in increased rates of severe and uncontrolled asthma responsible for 80% of the costs associated with asthma management.
Current National Institutes of Health (NIH) guidelines dictate asthma should be diagnosed early and treated aggressively before a case of mild asthma progresses to severe asthma with a much higher risk of asthma attacks and significantly higher treatment costs. Asthma cannot be cured, but it can be controlled to afford patients a life without restrictions. Despite a clear plan of action, compliance rates with NIH guidelines remain unsatisfactory, likely due to patients refusing to regularly perform the uncomfortable and sometimes complex methods currently prescribed for asthma monitoring.
BioLum plans to address these issues by providing a simple and effective method to monitor lung function and airway inflammation.